What we’ve seen so far.
6
Peer-reviewed publications
2
Animal species
Multiple
Disease models: Allergy, Autoimmune, Cancer and Transplant.
Published research has examined immune regulation, inflammatory activity, and defined treatment courses.
The signal has appeared more than once.
Across different models, the research has reported biological effects consistent with the AbstimX™ hypothesis.
Immune regulation
Inflammatory activity
Effects following defined treatment courses
Findings vary by study and model.
Naturally occurring disease.
AbstimX™ is currently being studied in dogs with naturally occurring allergic disease at an independent academic centre.
Clinical pilot underway.
Results are scheduled for 2027.
Canine dermatology is also a meaningful therapeutic market in its own right, making the program relevant both clinically and commercially.
Animal evidence is not human proof.
That is the next question:
Animal models
↓
Naturally occurring disease
↓
Human translation
What we are working towards.
Human efficacy
Human durability
Comparative clinical benefit